$FZMD
Fuse Medical, Inc.

2018 Form 10-K Financial Statement

#000156459019008819 Filed on March 21, 2019

View on sec.gov

Income Statement

Concept 2018 2017 Q4 2017
Revenue $26.34M $7.500M $26.41M
YoY Change -0.25% -70.3% 4552.37%
Cost Of Revenue $13.35M $3.720M $14.58M
YoY Change -8.43% -66.52% 7046.7%
Gross Profit $12.99M $3.780M $11.82M
YoY Change 9.85% -73.25% 3152.47%
Gross Profit Margin 49.31% 50.4% 44.78%
Selling, General & Admin $8.466M $3.590M $5.316M
YoY Change 59.27% -66.26% 27.45%
% of Gross Profit 65.18% 94.97% 44.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $49.69K $0.00 $14.52K
YoY Change 242.16% -100.0% -23.94%
% of Gross Profit 0.38% 0.0% 0.12%
Operating Expenses $14.95M $3.590M $10.97M
YoY Change 36.31% -66.29% -2.49%
Operating Profit -$1.958M $190.0K $858.9K
YoY Change -328.01% -94.54% -72.85%
Interest Expense $133.9K -$50.00K $161.7K
YoY Change -17.15% -54.55% 10.04%
% of Operating Profit -26.32% 18.82%
Other Income/Expense, Net -$133.9K $0.00 -$118.4K
YoY Change 13.17% -19.44%
Pretax Income $3.571M $150.0K $740.5K
YoY Change 382.21% -95.51% -75.45%
Income Tax -$386.8K $40.00K $40.82K
% Of Pretax Income -10.83% 26.67% 5.51%
Net Earnings $3.958M $100.0K $699.7K
YoY Change 465.63% -97.01% -76.8%
Net Earnings / Revenue 15.02% 1.33% 2.65%
Basic Earnings Per Share $0.06 $0.04
Diluted Earnings Per Share $0.05 $3.532K $0.04
COMMON SHARES
Basic Shares Outstanding 67.67M 16.03M
Diluted Shares Outstanding 73.93M 19.47M

Balance Sheet

Concept 2018 2017 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $844.3K $800.0K $804.7K
YoY Change 4.92% 2.56% 3.37%
Cash & Equivalents $844.3K $804.7K $804.7K
Short-Term Investments
Other Short-Term Assets $29.55K $30.00K $32.47K
YoY Change -8.99% 50.0% 41.05%
Inventory $11.08M $10.63M $10.63M
Prepaid Expenses
Receivables $5.226M $6.570M $6.570M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.18M $18.03M $18.03M
YoY Change -4.76% 2290.57% -3.75%
LONG-TERM ASSETS
Property, Plant & Equipment $42.97K $16.90K $16.90K
YoY Change 154.26% 89.17% 14.58%
Goodwill $820.7K
YoY Change 0.08%
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0%
Other Assets $761.0K $380.0K $375.3K
YoY Change 102.78%
Total Long-Term Assets $4.997M $1.213M $1.213M
YoY Change 312.02% -93.56% 44.52%
TOTAL ASSETS
Total Short-Term Assets $17.18M $18.03M $18.03M
Total Long-Term Assets $4.997M $1.213M $1.213M
Total Assets $22.17M $19.25M $19.25M
YoY Change 15.2% -1.68% -1.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.713M $2.588M $2.588M
YoY Change 4.82% 5.51% 5.51%
Accrued Expenses $2.784M $1.831M $1.831M
YoY Change 52.09% 35816.79% -40.33%
Deferred Revenue
YoY Change
Short-Term Debt $1.627M $3.570M $3.565M
YoY Change -54.35% 3.18% 3.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.125M $7.984M $7.984M
YoY Change -10.76% -11.05% -11.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.58M $19.24M $19.24M
YoY Change -29.43%
Total Long-Term Liabilities $13.58M $19.24M $19.24M
YoY Change -29.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.125M $7.984M $7.984M
Total Long-Term Liabilities $13.58M $19.24M $19.24M
Total Liabilities $20.71M $27.23M $27.23M
YoY Change -23.95% 8502.18% 203.34%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock -$7.982M
YoY Change -338.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.467M -$7.982M -$7.982M
YoY Change
Total Liabilities & Shareholders Equity $22.17M $19.25M $19.25M
YoY Change 15.2% 2408.93% -1.68%

Cashflow Statement

Concept 2018 2017 Q4 2017
OPERATING ACTIVITIES
Net Income $3.958M $100.0K $699.7K
YoY Change 465.63% -97.01% -76.8%
Depreciation, Depletion And Amortization $49.69K $0.00 $14.52K
YoY Change 242.16% -100.0% -23.94%
Cash From Operating Activities $2.480M -$100.0K $1.605M
YoY Change 54.56% -103.52% -42.5%
INVESTING ACTIVITIES
Capital Expenditures $41.84K $0.00 $20.33K
YoY Change 105.75%
Acquisitions $63.10K
YoY Change
Other Investing Activities -$63.10K $0.00 $8.730K
YoY Change -822.79% -100.0% -98.67%
Cash From Investing Activities -$104.9K $0.00 -$11.60K
YoY Change 804.46% -100.0% -101.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.335M 30.00K -1.567M
YoY Change 49.07% -100.99% -46.55%
NET CHANGE
Cash From Operating Activities 2.480M -100.0K 1.605M
Cash From Investing Activities -104.9K 0.000 -11.60K
Cash From Financing Activities -2.335M 30.00K -1.567M
Net Change In Cash 39.60K -70.00K 26.27K
YoY Change 50.75% -114.89% -94.9%
FREE CASH FLOW
Cash From Operating Activities $2.480M -$100.0K $1.605M
Capital Expenditures $41.84K $0.00 $20.33K
Free Cash Flow $2.438M -$100.0K $1.584M
YoY Change 53.9% -103.52% -43.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
844314
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
804715
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5225999
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6570382
CY2018Q4 us-gaap Inventory Net
InventoryNet
11075889
CY2017Q4 us-gaap Inventory Net
InventoryNet
10626769
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29553
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32466
CY2018Q4 us-gaap Assets Current
AssetsCurrent
17175755
CY2017Q4 us-gaap Assets Current
AssetsCurrent
18034332
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42974
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16895
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
760993
CY2018Q2 dei Entity Public Float
EntityPublicFloat
6959716
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74600181
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Trading Symbol
TradingSymbol
FZMD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2913
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2479900
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41838
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-917689
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1881556
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2017 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
27000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3915000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.21
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2018Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
140272
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
232793
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.108
CY2018 us-gaap Revenues
Revenues
26342038
CY2017 us-gaap Operating Expenses
OperatingExpenses
10965933
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
308026
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
375278
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1288040
CY2018Q4 us-gaap Goodwill
Goodwill
2905089
CY2017Q4 us-gaap Goodwill
Goodwill
820650
CY2018Q4 us-gaap Assets
Assets
22172851
CY2017Q4 us-gaap Assets
Assets
19247155
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2712919
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2588091
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2784271
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1830679
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1477448
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3415351
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7124638
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7984121
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13581529
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
19244543
CY2018Q4 us-gaap Liabilities
Liabilities
20706167
CY2017Q4 us-gaap Liabilities
Liabilities
27228664
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
714891
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
671583
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-8653092
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
751793
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1466684
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-7981509
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22172851
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19247155
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
667963
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
499099
CY2018Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1711871
CY2017Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1110742
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74600181
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69158308
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71489066
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65890808
CY2017 us-gaap Revenues
Revenues
26407206
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8466128
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5315657
CY2018 fzmd Commissions
Commissions
6431967
CY2017 fzmd Commissions
Commissions
5641122
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5367
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49685
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14521
CY2018 us-gaap Operating Expenses
OperatingExpenses
14947780
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-1958300
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
858857
CY2018 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
5663014
CY2018 us-gaap Interest Expense
InterestExpense
133944
CY2017 us-gaap Interest Expense
InterestExpense
161669
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
43308
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-133944
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-118361
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3570770
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
740496
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-386784
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40818
CY2018 us-gaap Net Income Loss
NetIncomeLoss
3957554
CY2017 us-gaap Net Income Loss
NetIncomeLoss
699678
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68020348
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16027794
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70945602
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19473553
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
10599475
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
42609
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
-19244543
CY2017 fzmd Adjustments To Additional Paid In Capital Deferred Tax Asset
AdjustmentsToAdditionalPaidInCapitalDeferredTaxAsset
375278
CY2017 fzmd Adjustments To Additional Paid In Capital Member Contribution
AdjustmentsToAdditionalPaidInCapitalMemberContribution
1738620
CY2017 fzmd Adjustments To Additional Paid In Capital Member Distribution
AdjustmentsToAdditionalPaidInCapitalMemberDistribution
2192626
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
210888
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
624041
CY2018 fzmd Working Capital Purchase Price Adjustment
WorkingCapitalPurchasePriceAdjustment
397463
CY2018 fzmd Adjustments To Additional Paid In Capital Inventory Contributed By Stockholder
AdjustmentsToAdditionalPaidInCapitalInventoryContributedByStockholder
1547807
CY2018 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
3281757
CY2018 fzmd Adjustment To Purchase Price Accounting
AdjustmentToPurchasePriceAccounting
223609
CY2018 us-gaap Profit Loss
ProfitLoss
3957554
CY2017 us-gaap Profit Loss
ProfitLoss
699678
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
834929
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
42609
CY2018 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
168864
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-431272
CY2017 fzmd Gain Loss On Disposal Of Property And Equipment
GainLossOnDisposalOfPropertyAndEquipment
5067
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-82824
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
178477
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
843820
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1236527
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
848
CY2017 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
3822
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20334
CY2017 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
8732
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
63097
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104935
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11602
CY2018 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1937903
CY2017 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
110004
CY2017 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
273044
CY2017 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
1949714
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2335366
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1566666
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
39599
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26268
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
778447
CY2018 us-gaap Interest Paid Net
InterestPaidNet
107521
CY2017 us-gaap Interest Paid Net
InterestPaidNet
139507
CY2018 fzmd Inventory Contributed By Stockholder
InventoryContributedByStockholder
2063742
CY2017 fzmd Member Contributions Of Inventory
MemberContributionsOfInventory
1465576
CY2017 fzmd Member Distributions Of Inventory
MemberDistributionsOfInventory
242912
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with GAAP, requires the Company&#8217;s management to make estimates and assumptions that affect the Company&#8217;s reported amounts in the consolidated financial statements.&#160;&#160;Actual results could differ from those estimates. Significant estimates on the accompanying consolidated financial statements include the valuation of inventories, the Company&#8217;s effective income tax rate, and the recoverability of deferred tax assets, which are based upon the Company&#8217;s management expectation of future taxable income and allowable deductions and the fair value calculations of stock-based compensation and earn-out (&#8220;<font style="font-weight:bold;">Earn-Out</font>&#8221;) liability.</p>
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in the accompanying consolidated statements of operations have been reclassified to conform to the current presentation. State income tax expense has been reclassified from selling, general, administrative and other expenses to income tax expense (benefit).</p>
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3000
CY2018 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2018 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018 fzmd Outstanding Common Stock Equivalents Included With Diluted Net Earnings Per Share
OutstandingCommonStockEquivalentsIncludedWithDilutedNetEarningsPerShare
1300000
CY2017 fzmd Outstanding Common Stock Equivalents Included With Diluted Net Earnings Per Share
OutstandingCommonStockEquivalentsIncludedWithDilutedNetEarningsPerShare
700000
CY2018 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
3915000
CY2017 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
1302052
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5663014
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
322693
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
537388
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2018 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
84273
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68800
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26960
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25826
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10065
CY2018 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
27000
CY2018 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
CY2018 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C
CY2018 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc.
CY2018 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2018 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2018 fzmd Operating Lease Requires Monthly Payments
OperatingLeaseRequiresMonthlyPayments
14000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
5000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
500
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8500
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0722
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.0722
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02785
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1302052
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3930000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1315000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2052
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1340000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.04
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.96
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.11
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
443000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
443000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.96
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
48711
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
40818
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
48711
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40818
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-435495
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-435495
CY2017 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
216793
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
383744
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
28128
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1001730
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
232835
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
7902
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
240737
CY2018Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
760993
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
760993
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
172704
CY2017Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
81927
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
57458
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
25792
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
337881
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
40342
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2945
CY2017Q4 fzmd Deferred Tax Assets Liabilities
DeferredTaxAssetsLiabilities
37397
CY2017Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
375278
CY2018 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.328
CY2017 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.038
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-308026
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
375278
CY2017 fzmd Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
385715
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1032348
CY2018 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2019
CY2018 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2037
CY2018 us-gaap Open Tax Year
OpenTaxYear
2015 2016 2017
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.205
CY2018 fzmd Effective Income Tax Rate Reconciliation Flow Through Structure
EffectiveIncomeTaxRateReconciliationFlowThroughStructure
0.000
CY2017 fzmd Effective Income Tax Rate Reconciliation Flow Through Structure
EffectiveIncomeTaxRateReconciliationFlowThroughStructure
-0.593
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.058

Files In Submission

Name View Source Status
0001564590-19-008819-index-headers.html Edgar Link pending
0001564590-19-008819-index.html Edgar Link pending
0001564590-19-008819.txt Edgar Link pending
0001564590-19-008819-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10k_20181231.htm Edgar Link pending
fzmd-20181231.xml Edgar Link completed
fzmd-20181231.xsd Edgar Link pending
fzmd-20181231_cal.xml Edgar Link unprocessable
fzmd-20181231_def.xml Edgar Link unprocessable
fzmd-20181231_lab.xml Edgar Link unprocessable
fzmd-20181231_pre.xml Edgar Link unprocessable
fzmd-ex1014_85.htm Edgar Link pending
fzmd-ex1015_84.htm Edgar Link pending
fzmd-ex1016_83.htm Edgar Link pending
fzmd-ex1017_81.htm Edgar Link pending
fzmd-ex1018_82.htm Edgar Link pending
fzmd-ex1019_80.htm Edgar Link pending
fzmd-ex1020_79.htm Edgar Link pending
fzmd-ex1021_77.htm Edgar Link pending
fzmd-ex1022_76.htm Edgar Link pending
fzmd-ex1023_78.htm Edgar Link pending
fzmd-ex1024_74.htm Edgar Link pending
fzmd-ex1025_75.htm Edgar Link pending
fzmd-ex1026_98.htm Edgar Link pending
fzmd-ex1027_97.htm Edgar Link pending
fzmd-ex1028_96.htm Edgar Link pending
fzmd-ex1029_95.htm Edgar Link pending
fzmd-ex1030_93.htm Edgar Link pending
fzmd-ex1031_92.htm Edgar Link pending
fzmd-ex1032_91.htm Edgar Link pending
fzmd-ex1033_90.htm Edgar Link pending
fzmd-ex1034_94.htm Edgar Link pending
fzmd-ex1035_89.htm Edgar Link pending
fzmd-ex1036_88.htm Edgar Link pending
fzmd-ex1037_87.htm Edgar Link pending
fzmd-ex1038_86.htm Edgar Link pending
fzmd-ex1039_103.htm Edgar Link pending
fzmd-ex1040_104.htm Edgar Link pending
fzmd-ex1041_102.htm Edgar Link pending
fzmd-ex1042_101.htm Edgar Link pending
fzmd-ex1043_99.htm Edgar Link pending
fzmd-ex1044_100.htm Edgar Link pending
fzmd-ex1045_107.htm Edgar Link pending
fzmd-ex1046_105.htm Edgar Link pending
fzmd-ex1047_106.htm Edgar Link pending
fzmd-ex1048_124.htm Edgar Link pending
fzmd-ex1049_123.htm Edgar Link pending
fzmd-ex104_126.htm Edgar Link pending
fzmd-ex1050_122.htm Edgar Link pending
fzmd-ex1051_121.htm Edgar Link pending
fzmd-ex1052_120.htm Edgar Link pending
fzmd-ex1053_119.htm Edgar Link pending
fzmd-ex1054_118.htm Edgar Link pending
fzmd-ex1055_117.htm Edgar Link pending
fzmd-ex1056_116.htm Edgar Link pending
fzmd-ex1057_114.htm Edgar Link pending
fzmd-ex1058_115.htm Edgar Link pending
fzmd-ex1059_113.htm Edgar Link pending
fzmd-ex105_125.htm Edgar Link pending
fzmd-ex1060_112.htm Edgar Link pending
fzmd-ex1061_111.htm Edgar Link pending
fzmd-ex1062_110.htm Edgar Link pending
fzmd-ex1063_108.htm Edgar Link pending
fzmd-ex1064_109.htm Edgar Link pending
fzmd-ex211_127.htm Edgar Link pending
fzmd-ex231_2373.htm Edgar Link pending
fzmd-ex311_16.htm Edgar Link pending
fzmd-ex312_14.htm Edgar Link pending
fzmd-ex321_9.htm Edgar Link pending
g1rdntfefghq000001.jpg Edgar Link pending
g3srxj1jnbfa000001.jpg Edgar Link pending
g5etmiozow3n000001.jpg Edgar Link pending
g5ff40ioeylq000001.jpg Edgar Link pending
g5ff40ioeylq000016.jpg Edgar Link pending
g5ff40ioeylq000018.jpg Edgar Link pending
g5ff40ioeylq000019.jpg Edgar Link pending
g5ff40ioeylq000020.jpg Edgar Link pending
g5ff40ioeylq000022.jpg Edgar Link pending
g5ff40ioeylq000024.jpg Edgar Link pending
g5ff40ioeylq000026.jpg Edgar Link pending
g5ff40ioeylq000028.jpg Edgar Link pending
g5ff40ioeylq000030.jpg Edgar Link pending
g5ff40ioeylq000032.jpg Edgar Link pending
g5ff40ioeylq000033.jpg Edgar Link pending
g5ff40ioeylq000034.jpg Edgar Link pending
g5ff40ioeylq000035.jpg Edgar Link pending
g5ff40ioeylq000037.jpg Edgar Link pending
g5ff40ioeylq000039.jpg Edgar Link pending
g5ff40ioeylq000041.jpg Edgar Link pending
g5ff40ioeylq000043.jpg Edgar Link pending
g5ff40ioeylq000045.jpg Edgar Link pending
g5ff40ioeylq000047.jpg Edgar Link pending
gadqbf4fswrn000001.jpg Edgar Link pending
gafuryc5witb000001.jpg Edgar Link pending
gdjqqo1j04h0000001.jpg Edgar Link pending
gdjqqo1j04h0000002.jpg Edgar Link pending
gdjqqo1j04h0000003.jpg Edgar Link pending
gdjqqo1j04h0000004.jpg Edgar Link pending
gdjqqo1j04h0000005.jpg Edgar Link pending
gdjqqo1j04h0000006.jpg Edgar Link pending
gdjqqo1j04h0000007.jpg Edgar Link pending
gdjqqo1j04h0000008.jpg Edgar Link pending
gdjqqo1j04h0000009.jpg Edgar Link pending
gds5kw2l2123000001.jpg Edgar Link pending
gds5kw2l2123000002.jpg Edgar Link pending
gffvvbsnn2ru000001.jpg Edgar Link pending
ggg0uj1lfbjt000001.jpg Edgar Link pending
gggwhuxvynqh000001.jpg Edgar Link pending
gggwhuxvynqh000002.jpg Edgar Link pending
gggwhuxvynqh000003.jpg Edgar Link pending
gggwhuxvynqh000004.jpg Edgar Link pending
gggwhuxvynqh000005.jpg Edgar Link pending
gggwhuxvynqh000006.jpg Edgar Link pending
gggwhuxvynqh000007.jpg Edgar Link pending
gggwhuxvynqh000008.jpg Edgar Link pending
gggwhuxvynqh000009.jpg Edgar Link pending
gggwhuxvynqh000010.jpg Edgar Link pending
gggwhuxvynqh000011.jpg Edgar Link pending
gggwhuxvynqh000012.jpg Edgar Link pending
gggwhuxvynqh000013.jpg Edgar Link pending
gggwhuxvynqh000014.jpg Edgar Link pending
gggwhuxvynqh000015.jpg Edgar Link pending
gggwhuxvynqh000016.jpg Edgar Link pending
gggwhuxvynqh000017.jpg Edgar Link pending
gggwhuxvynqh000018.jpg Edgar Link pending
gggwhuxvynqh000019.jpg Edgar Link pending
gggwhuxvynqh000020.jpg Edgar Link pending
gggwhuxvynqh000021.jpg Edgar Link pending
gggwhuxvynqh000022.jpg Edgar Link pending
gggwhuxvynqh000023.jpg Edgar Link pending
gggwhuxvynqh000024.jpg Edgar Link pending
gggwhuxvynqh000025.jpg Edgar Link pending
gggwhuxvynqh000026.jpg Edgar Link pending
gggwhuxvynqh000027.jpg Edgar Link pending
gggwhuxvynqh000028.jpg Edgar Link pending
gggwhuxvynqh000029.jpg Edgar Link pending
gggwhuxvynqh000030.jpg Edgar Link pending
gggwhuxvynqh000031.jpg Edgar Link pending
gggwhuxvynqh000032.jpg Edgar Link pending
gggwhuxvynqh000033.jpg Edgar Link pending
gggwhuxvynqh000034.jpg Edgar Link pending
gggwhuxvynqh000035.jpg Edgar Link pending
gggwhuxvynqh000036.jpg Edgar Link pending
gggwhuxvynqh000037.jpg Edgar Link pending
gggwhuxvynqh000038.jpg Edgar Link pending
gggwhuxvynqh000039.jpg Edgar Link pending
gggwhuxvynqh000040.jpg Edgar Link pending
gggwhuxvynqh000041.jpg Edgar Link pending
gggwhuxvynqh000042.jpg Edgar Link pending
gggwhuxvynqh000043.jpg Edgar Link pending
gggwhuxvynqh000044.jpg Edgar Link pending
gggwhuxvynqh000045.jpg Edgar Link pending
gggwhuxvynqh000046.jpg Edgar Link pending
gggwhuxvynqh000047.jpg Edgar Link pending
gggwhuxvynqh000048.jpg Edgar Link pending
gh2uzoicvnc0000001.jpg Edgar Link pending
gh2uzoicvnc0000002.jpg Edgar Link pending
gh2uzoicvnc0000003.jpg Edgar Link pending
gj5ocgvs4wa3000001.jpg Edgar Link pending
gj5ocgvs4wa3000002.jpg Edgar Link pending
glrmusprsk2d000001.jpg Edgar Link pending
gobfqzmv1rn4000001.jpg Edgar Link pending
gobfqzmv1rn4000002.jpg Edgar Link pending
gowg3010yuta000001.jpg Edgar Link pending
gqgtnnorg4qd000001.jpg Edgar Link pending
gqo3dpxkjfap000001.jpg Edgar Link pending
gsqnje3gaeih000001.jpg Edgar Link pending
gsqnje3gaeih000002.jpg Edgar Link pending
gsqnje3gaeih000003.jpg Edgar Link pending
gsqnje3gaeih000004.jpg Edgar Link pending
gsqnje3gaeih000005.jpg Edgar Link pending
gsqnje3gaeih000006.jpg Edgar Link pending
gsqnje3gaeih000007.jpg Edgar Link pending
gst1hjddrfmu000001.jpg Edgar Link pending
gst1hjddrfmu000002.jpg Edgar Link pending
gst1hjddrfmu000003.jpg Edgar Link pending
gst1hjddrfmu000004.jpg Edgar Link pending
gst1hjddrfmu000005.jpg Edgar Link pending
gst1hjddrfmu000006.jpg Edgar Link pending
gst1hjddrfmu000007.jpg Edgar Link pending
gst1hjddrfmu000008.jpg Edgar Link pending
gst1hjddrfmu000009.jpg Edgar Link pending
gst1hjddrfmu000010.jpg Edgar Link pending
gst1hjddrfmu000011.jpg Edgar Link pending
gv5ofdq31ykt000001.jpg Edgar Link pending
gwlb431tilrg000001.jpg Edgar Link pending
gwwjxrq0edjq000001.jpg Edgar Link pending
gwwjxrq0edjq000004.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending